Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Total Current Liabilities (2016 - 2019)

Historic Total Current Liabilities for Soleno Therapeutics (SLNO) over the last 7 years, with Q3 2019 value amounting to $3.5 million.

  • Soleno Therapeutics' Total Current Liabilities rose 3771.93% to $3.5 million in Q3 2019 from the same period last year, while for Sep 2019 it was $3.5 million, marking a year-over-year increase of 3771.93%. This contributed to the annual value of $1.9 million for FY2018, which is 830.93% up from last year.
  • Per Soleno Therapeutics' latest filing, its Total Current Liabilities stood at $3.5 million for Q3 2019, which was up 3771.93% from $2.9 million recorded in Q2 2019.
  • In the past 5 years, Soleno Therapeutics' Total Current Liabilities registered a high of $13.3 million during Q2 2015, and its lowest value of $1.1 million during Q1 2015.
  • For the 5-year period, Soleno Therapeutics' Total Current Liabilities averaged around $3.0 million, with its median value being $2.1 million (2017).
  • In the last 5 years, Soleno Therapeutics' Total Current Liabilities soared by 27769.42% in 2015 and then crashed by 8575.92% in 2016.
  • Over the past 5 years, Soleno Therapeutics' Total Current Liabilities (Quarter) stood at $3.2 million in 2015, then crashed by 46.52% to $1.7 million in 2016, then rose by 1.5% to $1.7 million in 2017, then grew by 8.31% to $1.9 million in 2018, then surged by 84.02% to $3.5 million in 2019.
  • Its Total Current Liabilities was $3.5 million in Q3 2019, compared to $2.9 million in Q2 2019 and $2.2 million in Q1 2019.